ATRS Recent News Antares Pharma to Present at the

ATRS Recent News

Antares Pharma to Present at the Cowen and Company 34th Annual Healthcare Conference Business Wire - Wed Feb 26, 6:00AM CST
Today's Biggest Biotech Stories: Antares Pharma Inc., BioCryst Pharmaceuticals Inc., and Raptor Phar Motley Fool - Thu Feb 20, 9:02AM CST
Antares Pharma Announces Positive Results from the VIBEX QuickShot Pharmacokinetic Study in Testosterone Deficient Men Business Wire - Thu Feb 20, 6:00AM CST
Antares Pharma, Inc. [ATRS] to Ring The NASDAQ Stock Market Opening Bell GlobeNewswire - Wed Feb 19, 9:00AM CST
Antares Pharma to Participate in the 2014 RBC Capital Markets' Global Healthcare Conference Business Wire - Wed Feb 19, 6:00AM CST
2013 Report on the International North America Injectable Drug Delivery Market - Forecasts to 2017 M2 - Thu Jan 23, 5:56AM CST
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children Business Wire - Wed Jan 15, 6:00AM CST
Conferences, Preliminary Revenues, Board Changes, Shareholders' Meeting Results, and Clinical Trial Initiation - Research Report on Antares, Quidel, bluebird bio, Given Imaging, and Immunomedics PR Newswire - Tue Jan 14, 7:00AM CST
Is This the Top for Antares Pharma Inc (ATRS)? - Tale of the Tape Zacks Investment Research - Mon Jan 13, 6:13AM CST
Antares Pharma to Present at the 32nd Annual J.P. Morgan Healthcare Conference Business Wire - Mon Jan 06, 11:59AM CST